210 related articles for article (PubMed ID: 33662596)
1. Noncontrast MRI for Hepatocellular Carcinoma Detection: A Systematic Review and Meta-analysis - A Potential Surveillance Tool?
Chan MV; Huo YR; Trieu N; Mitchelle A; George J; He E; Lee AU; Chang J; Yang J
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):44-56.e2. PubMed ID: 33662596
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data-a pilot study.
McNamara MM; Thomas JV; Alexander LF; Little MD; Bolus DN; Li YE; Morgan DE
Abdom Radiol (NY); 2018 Oct; 43(10):2686-2692. PubMed ID: 29500648
[TBL] [Abstract][Full Text] [Related]
3. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
4. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies.
Kim YY; Lee S; Shin J; Son WJ; Roh YH; Hwang JA; Lee JE
Eur Radiol; 2022 Oct; 32(10):6723-6729. PubMed ID: 35849177
[TBL] [Abstract][Full Text] [Related]
7. Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
Whang S; Choi MH; Choi JI; Youn SY; Kim DH; Rha SE
Eur Radiol; 2020 Aug; 30(8):4150-4163. PubMed ID: 32166493
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Computed Tomography-Detected Arterial Hyperenhancing-Only Lesions in Patients at Risk of Hepatocellular Carcinoma: Can Non-Contrast Magnetic Resonance Imaging Be Used for Sequential Imaging?
Park SH; Kim B; Kim SY; Choi SJ; Huh J; Kim HJ; Kim KW; Lee SS
Korean J Radiol; 2020 Mar; 21(3):280-289. PubMed ID: 32090520
[TBL] [Abstract][Full Text] [Related]
9. Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound.
Park HJ; Jang HY; Kim SY; Lee SJ; Won HJ; Byun JH; Choi SH; Lee SS; An J; Lim YS
J Hepatol; 2020 Apr; 72(4):718-724. PubMed ID: 31836549
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients.
Park MS; Kim S; Patel J; Hajdu CH; Do RK; Mannelli L; Babb JS; Taouli B
Hepatology; 2012 Jul; 56(1):140-8. PubMed ID: 22370974
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
[TBL] [Abstract][Full Text] [Related]
12. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid.
Besa C; Lewis S; Pandharipande PV; Chhatwal J; Kamath A; Cooper N; Knight-Greenfield A; Babb JS; Boffetta P; Padron N; Sirlin CB; Taouli B
Abdom Radiol (NY); 2017 Jan; 42(1):179-190. PubMed ID: 27448609
[TBL] [Abstract][Full Text] [Related]
14. Abbreviated MRI for Secondary Surveillance of Recurrent Hepatocellular Carcinoma After Presumed Curative Treatment.
Jeon SK; Lee DH; Hur BY; Park SJ; Kim SW; Park J; Suh KS; Lee KW; Yi NJ; Han JK
J Magn Reson Imaging; 2023 Nov; 58(5):1375-1383. PubMed ID: 36825827
[TBL] [Abstract][Full Text] [Related]
15. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Lee S; Kim SS; Roh YH; Choi JY; Park MS; Kim MJ
Liver Int; 2020 Jun; 40(6):1488-1497. PubMed ID: 32145134
[TBL] [Abstract][Full Text] [Related]
17. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
[TBL] [Abstract][Full Text] [Related]
18. Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.
Gupta P; Soundararajan R; Patel A; Kumar-M P; Sharma V; Kalra N
J Hepatol; 2021 Jul; 75(1):108-119. PubMed ID: 33548385
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of non-contrast magnetic resonance imaging as an imaging surveillance tool for hepatocellular carcinoma in at-risk patients.
Liu JKJ; Lee CH; Tan CH
Singapore Med J; 2022 Apr; 63(4):203-208. PubMed ID: 32798363
[TBL] [Abstract][Full Text] [Related]
20. Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma.
Kim YK; Kim YK; Park HJ; Park MJ; Lee WJ; Choi D
Magn Reson Imaging; 2014 Jul; 32(6):610-8. PubMed ID: 24702980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]